AAAAAA

   
Results: 1-25 | 26-50 | 51-74
Results: 1-25/74

Authors: CIGNARELLA A BRENNHAUSEN B VONECKARDSTEIN A ASSMANN G CULLEN P
Citation: A. Cignarella et al., DIFFERENTIAL-EFFECTS OF LOVASTATIN ON THE TRAFFICKING OF ENDOGENOUS AND LIPOPROTEIN-DERIVED CHOLESTEROL IN HUMAN MONOCYTE-DERIVED MACROPHAGES, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1322-1329

Authors: RUST S WALTER M FUNKE H VONECKARDSTEIN A CULLEN P KROES HY HORDIJK R GEISEL J KASTELEIN J MOLHUIZEN HOF SCHREINER M MISCHKE A HASHMANN HW ASSMANN G
Citation: S. Rust et al., ASSIGNMENT OF TANGIER-DISEASE TO CHROMOSOME 9Q31 BY A GRAPHICAL LINKAGE EXCLUSION STRATEGY, Nature genetics, 20(1), 1998, pp. 96-98

Authors: CULLEN P VONECKARDSTEIN A ASSMANN G
Citation: P. Cullen et al., DIAGNOSIS AND MANAGEMENT OF NEW CARDIOVASCULAR RISK-FACTORS, European heart journal, 19, 1998, pp. 13-19

Authors: UHL W CHAN DW JONES K KELLEY C ASSMANN G VONECKARDSTEIN A SAGERS A YVERT JP SCHNEIDER AM TORRALBA A FUENTESARDERIU X DELAPRESA BG VIVES M GREILING H EBERLE A NIEDERAU CM CREMER P REITER W VOGESER M NEUMEIER D LUPPA P HUBER U
Citation: W. Uhl et al., ELECSYS(R) CEA, PSA AND AFP - CLINICAL-RESULTS OF A MULTICENTER EVALUATION, Wiener Klinische Wochenschrift, 110, 1998, pp. 51-61

Authors: ZHU YH BELLOSTA S LANGER C BERNINI F PITAS RE MAHLEY RW ASSMANN G VONECKARDSTEIN A
Citation: Yh. Zhu et al., LOW-DOSE EXPRESSION OF A HUMAN APOLIPOPROTEIN-E TRANSGENE IN MACROPHAGES RESTORES CHOLESTEROL EFFLUX CAPACITY OF APOLIPOPROTEIN E-DEFICIENTMOUSE PLASMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7585-7590

Authors: BANSCH D CHENHAUDENSCHILD C DIRKESKERSTING A SCHULTE H ASSMANN G VONECKARDSTEIN A
Citation: D. Bansch et al., BASAL GROWTH-HORMONE LEVELS IN WOMEN ARE POSITIVELY CORRELATED WITH HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-A-I INDEPENDENTLY OF INSULIN-LIKE-GROWTH-FACTOR-1 OR INSULIN, Metabolism, clinical and experimental, 47(3), 1998, pp. 339-344

Authors: REAL JT ASCASO JF SANCHIS J ARANDA A VONECKARDSTEIN A CARMENA R
Citation: Jt. Real et al., CLINICAL AND BIOCHEMICAL CHARACTERISTICS OF A NEW CASE OF TANGIER-DISEASE IN SPAIN, Medicina Clinica, 110(9), 1998, pp. 344-346

Authors: VONECKARDSTEIN A CHIRAZI A SCHULERLUTTMANN S WALTER M KASTELEIN JJP GEISEL J REAL JT MICCOLI R NOSEDA G HOBBEL G ASSMANN G
Citation: A. Voneckardstein et al., PLASMA AND FIBROBLASTS OF TANGIER-DISEASE PATIENTS ARE DISTURBED IN TRANSFERRING PHOSPHOLIPIDS ONTO APOLIPOPROTEIN-A-I, Journal of lipid research, 39(5), 1998, pp. 987-998

Authors: CULLEN P CIGNARELLA A BRENNHAUSEN B MOHR S ASSMANN G VONECKARDSTEIN A
Citation: P. Cullen et al., PHENOTYPE-DEPENDENT DIFFERENCES IN APOLIPOPROTEIN-E METABOLISM AND INCHOLESTEROL HOMEOSTASIS IN HUMAN MONOCYTE-DERIVED MACROPHAGES, The Journal of clinical investigation, 101(8), 1998, pp. 1670-1677

Authors: HUANG YD LIU XQ RALL SC TAYLOR JM VONECKARDSTEIN A ASSMANN G MAHLEY RW
Citation: Yd. Huang et al., OVEREXPRESSION AND ACCUMULATION OF APOLIPOPROTEIN-E AS A CAUSE OF HYPERTRIGLYCERIDEMIA, The Journal of biological chemistry, 273(41), 1998, pp. 26388-26393

Authors: JAMES RW GARIN MCB CALABRESI L MICCOLI R VONECKARDSTEIN A TILLYKIESI M TASKINEN MR ASSMANN G FRANCESCHINI G
Citation: Rw. James et al., MODULATED SERUM ACTIVITIES AND CONCENTRATIONS OF PARAOXONASE IN HIGH-DENSITY-LIPOPROTEIN DEFICIENCY STATES, Atherosclerosis (Amsterdam), 139(1), 1998, pp. 77-82

Authors: VONECKARDSTEIN A HUANG YD KASTELEIN JJP GEISEL J REAL JT KUIVENHOVEN JA MICCOLI R NOSEDA G ASSMANN G
Citation: A. Voneckardstein et al., LIPID-FREE APOLIPOPROTEIN (APO) A-I IS CONVERTED INTO ALPHA-MIGRATINGHIGH-DENSITY-LIPOPROTEINS BY LIPOPROTEIN-DEPLETED PLASMA OF NORMOLIPIDEMIC DONORS AND APO A-I-DEFICIENT PATIENTS BUT NOT OF TANGIER-DISEASEPATIENTS, Atherosclerosis, 138(1), 1998, pp. 25-34

Authors: VONECKARDSTEIN A ASSMANN G
Citation: A. Voneckardstein et G. Assmann, HIGH-DENSITY-LIPOPROTEINS AND REVERSE CHOLESTEROL TRANSPORT - LESSONSFROM MUTATIONS, Atherosclerosis (Amsterdam), 137, 1998, pp. 7-11

Authors: VONECKARDSTEIN A ASSMANN G
Citation: A. Voneckardstein et G. Assmann, HOMOCYSTEINE AND ATHEROGENESIS, Der Internist, 39(2), 1998, pp. 214-215

Authors: HUANG YD ZHU YH LANGER C RAABE M WU SL WIESENHUTTER B SEEDORF U MAEDA N ASSMANN G VONECKARDSTEIN A
Citation: Yd. Huang et al., EFFECTS OF GENOTYPE AND DIET ON CHOLESTEROL EFFLUX INTO PLASMA AND LIPOPROTEINS OF NORMAL, APOLIPOPROTEIN A-I-DEFICIENT, AND APOLIPOPROTEINE-DEFICIENT MICE, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 2010-2019

Authors: KLEEMANN A ECKERT S VONECKARDSTEIN A LEPPER W SCHERNIKAU U GLEICHMANN U HANRATH P FLECK E NEISS A ASSMANN G BREITHARDT G
Citation: A. Kleemann et al., EFFECTS OF LOVASTATIN ON RESTENOSIS AFTER PTCA AND ON PROGRESSION OF CORONARY-ARTERY DISEASE - THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS PTCA TRIAL (CLAPT), Journal of the American College of Cardiology, 29(2), 1997, pp. 3874-3874

Authors: VONECKARDSTEIN A ASSMANN G
Citation: A. Voneckardstein et G. Assmann, PLASMA HOMOCYSTEINE LEVELS AND MORTALITY IN PATIENTS WITH CORONARY-ARTERY DISEASE, The New England journal of medicine, 337(22), 1997, pp. 1632-1632

Authors: BANSCH D DIRKESKERSTING A SCHULTE H ASSMANN G VONECKARDSTEIN A
Citation: D. Bansch et al., BASAL GROWTH-HORMONE LEVELS ARE POSITIVELY CORRELATED WITH HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN WOMEN, Metabolism, clinical and experimental, 46(9), 1997, pp. 1039-1043

Authors: MICCOLI R ZHU YH DAUM U WESSLING J HUANG YD NAVALESI R ASSMANN G VONECKARDSTEIN A
Citation: R. Miccoli et al., A NATURAL APOLIPOPROTEIN-A-I VARIANT, APOA-I(L141R)(PISA), INTERFERESWITH THE FORMATION OF ALPHA-HIGH DENSITY LIPOPROTEINS (HDL) BUT NOT WITH THE FORMATION OF PRE-BETA(1)-HDL AND INFLUENCES EFFLUX OF CHOLESTEROL INTO PLASMA, Journal of lipid research, 38(6), 1997, pp. 1242-1253

Authors: LEREN TP BAKKEN KS DAUM U OSE L BERG K ASSMANN G VONECKARDSTEIN A
Citation: Tp. Leren et al., HETEROZYGOSITY FOR APOLIPOPROTEIN A-I(R160L)(OSLO) IS ASSOCIATED WITHLOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND HDL-SUBCLASS LPA-I A-II BUT NORMAL LEVELS OF HDL-SUBCLASS LPA-I/, Journal of lipid research, 38(1), 1997, pp. 121-131

Authors: VONECKARDSTEIN A KLIESCH S NIESCHLAG E CHIRAZI A ASSMANN G BEHRE HM
Citation: A. Voneckardstein et al., SUPPRESSION OF ENDOGENOUS TESTOSTERONE IN YOUNG MEN INCREASES SERUM LEVELS OF HIGH-DENSITY-LIPOPROTEIN SUBCLASS LIPOPROTEIN A-I AND LIPOPROTEIN(A), The Journal of clinical endocrinology and metabolism, 82(10), 1997, pp. 3367-3372

Authors: MICCOLI R VONECKARDSTEIN A ASSMANN G ODOGUARDI L NAVALESI R
Citation: R. Miccoli et al., APOLIPOPROTEIN-A-I DEFICIENCY SYNDROMES AND REVERSE CHOLESTEROL TRANSPORT, Atherosclerosis, 135, 1997, pp. 4-4

Authors: ASSMANN G CULLEN P VONECKARDSTEIN A FUNKE H
Citation: G. Assmann et al., GENETIC DISSECTION OF HIGH-DENSITY-LIPOPROTEIN METABOLISM, Atherosclerosis, 134(1-2), 1997, pp. 5-5

Authors: TATARU MC JUNKER R SCHULTE H VONECKARDSTEIN A SCHONFELD R ASSMANN G KOHLER E
Citation: Mc. Tataru et al., THE IMPORTANCE OF LP(A), LP AI, APO AI, APO AII, CONVENTIONAL RISK-FACTORS ON THE SEVERITY OF CORONARY-ARTERY DISEASE (CAD), Atherosclerosis, 134(1-2), 1997, pp. 21-21

Authors: TATARU MC JUNKER R SCHULTE H VONECKARDSTEIN A SCHONFELD R ASSMANN G KOHLER E
Citation: Mc. Tataru et al., D-DIMERS AND FIBRINOGEN IN PATIENTS WITH LEFT VENTRICLE-DYSFUNCTION AFTER MYOCARDIAL-INFARCTION AND IN GENERALIZED ATHEROSCLEROSIS, Atherosclerosis, 134(1-2), 1997, pp. 195-196
Risultati: 1-25 | 26-50 | 51-74